Lethedoside A is primarily investigated for its potential neuroprotective properties. It has shown activity in reducing oxidative stress and inflammation in neuronal cells, making it a compound of interest in the study of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Research suggests it may help in preserving cell viability under stress conditions by modulating key signaling pathways involved in apoptosis and cellular defense. Due to its natural origin and observed low toxicity in preliminary studies, it is also being explored as a lead compound for developing therapeutic agents targeting brain health. Most current applications remain in the preclinical research phase, focusing on in vitro and animal models to evaluate efficacy and mechanism of action.